Literature DB >> 6957278

The immunological classification of leukaemia based on a rapid microcytotoxicity test.

R J Billing, K A Foon, M Linker-Israeli.   

Abstract

We describe a rapid, accurate, and reproducible cytotoxic antibody test for the immunological classification of leukaemia. Well characterized heteroantisera and monoclonal antibodies were distributed in a microcytotoxicity tray referred to as a leukaemia screening tray (LST). Leukaemia cells were tested for the presence of Ia-like, 'blast', thymocyte, common acute lymphoblastic leukaemia (cALL), and acute myeloblastic leukaemia (AML) antigens. Utilizing this technique, T ALL could be distinguished from non-T ALL, ALL and AML could be differentiated, the myeloid blast crisis of chronic myelogenous leukaemia (CML) could be distinguished from the lymphoid blast crisis, and the T lymphocyte and B lymphocyte lymphoid leukaemias were readily identified. It has been shown that subclassification of leukaemia according to surface markers, as described here, offers considerable improvement in the diagnosis and treatment of leukaemia over the classical morphological methodologies. Because the test can be completed in 2 hr and unlimited amounts of monoclonal antibodies are available, the LST or similar tests should become universally available in the future to supplement morphological data and replace other lengthy enzyme and rosetting tests.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6957278      PMCID: PMC1536651     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Two-chain subunit structure of HLA-D antigens.

Authors:  R Billing; M Safani; J Lesch
Journal:  Tissue Antigens       Date:  1977-10

2.  Heteroantisera against a blast cell antigen.

Authors:  R Billing; P I Terasaki; B Clark
Journal:  Clin Immunol Immunopathol       Date:  1979-08

3.  Acute lymphocytic leukemia-associated cell membrane antigen.

Authors:  R Billing; J Minowada; M Cline; B Clark; K Lee
Journal:  J Natl Cancer Inst       Date:  1978-08       Impact factor: 13.506

4.  Dual B and T markers in acute and chronic lymphocytic leukemia.

Authors:  K A Foon; R J Billing; P I Terasaki
Journal:  Blood       Date:  1980-01       Impact factor: 22.113

5.  Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study.

Authors:  S M Marks; D Baltimore; R McCaffrey
Journal:  N Engl J Med       Date:  1978-04-13       Impact factor: 91.245

6.  Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation.

Authors:  R J Winchester; G D Ross; C I Jarowski; C Y Wang; J Halper; H E Broxmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

7.  Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications.

Authors:  S Rosenthal; G P Canellos; J Whang-Peng; H R Gralnick
Journal:  Am J Med       Date:  1977-10       Impact factor: 4.965

8.  Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera.

Authors:  R J Winchester; P A Meyers; H E Broxmeyer; C Y Wang; M A Moore; H G Kunkel
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

9.  Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity.

Authors:  S M Fu; N Chiorazzi; C Y Wang; G Montrazeri; H G Kunkel; H S Ko; A B Gottlieb
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens.

Authors:  R L Evans; T J Faldetta; R E Humphreys; D M Pratt; E J Yunis; S F Schlossman
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.